Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 2
1954 1
1964 1
1974 2
1975 1
1976 1
1977 4
1978 4
1979 2
1980 3
1981 1
1982 6
1983 3
1984 5
1985 9
1986 4
1987 6
1988 5
1989 4
1990 5
1991 3
1992 8
1993 6
1994 1
1995 6
1996 4
1997 1
1998 2
1999 3
2000 4
2001 3
2002 5
2003 7
2004 2
2005 4
2006 3
2007 3
2008 5
2009 1
2010 4
2011 3
2012 5
2013 5
2014 9
2015 8
2016 3
2017 9
2018 11
2019 9
2020 11
2021 7
2022 12
2023 16
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

239 results

Results by year

Filters applied: . Clear all
Page 1
The Origins of Phenotypic Heterogeneity in Cancer.
Lenz G, Onzi GR, Lenz LS, Buss JH, Dos Santos JA, Begnini KR. Lenz G, et al. Among authors: buss jh. Cancer Res. 2022 Jan 1;82(1):3-11. doi: 10.1158/0008-5472.CAN-21-1940. Epub 2021 Nov 16. Cancer Res. 2022. PMID: 34785576 Review.
Therminator DNA Polymerase: Modified Nucleotides and Unnatural Substrates.
Gardner AF, Jackson KM, Boyle MM, Buss JA, Potapov V, Gehring AM, Zatopek KM, Corrêa IR Jr, Ong JL, Jack WE. Gardner AF, et al. Among authors: buss ja. Front Mol Biosci. 2019 Apr 24;6:28. doi: 10.3389/fmolb.2019.00028. eCollection 2019. Front Mol Biosci. 2019. PMID: 31069234 Free PMC article. Review.
Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG).
Ozga M, Nicolet D, Mrózek K, Yilmaz AS, Kohlschmidt J, Larkin KT, Blachly JS, Oakes CC, Buss J, Walker CJ, Orwick S, Jurinovic V, Rothenberg-Thurley M, Dufour A, Schneider S, Sauerland MC, Görlich D, Krug U, Berdel WE, Woermann BJ, Hiddemann W, Braess J, Subklewe M, Spiekermann K, Carroll AJ, Blum WG, Powell BL, Kolitz JE, Moore JO, Mayer RJ, Larson RA, Uy GL, Stock W, Metzeler KH, Grimes HL, Byrd JC, Salomonis N, Herold T, Mims AS, Eisfeld AK. Ozga M, et al. Among authors: buss j. Leukemia. 2024 Jan;38(1):45-57. doi: 10.1038/s41375-023-02068-8. Epub 2023 Nov 28. Leukemia. 2024. PMID: 38017103 Free PMC article.
Cancer Cell Fitness Is Dynamic.
Lenz LS, Faccioni JL, Bracco PA, Santos JAF, Pereira LC, Buss JH, Tamborindeguy MT, Torgo D, Monteiro T, Mantovani GB, Santo CN, Marcolin JC, Dalsin E, Vigo A, Callegari-Jacques SM, Silva AO, Onzi GR, Begnini KR, Lenz G. Lenz LS, et al. Among authors: buss jh. Cancer Res. 2021 Feb 15;81(4):1040-1051. doi: 10.1158/0008-5472.CAN-20-2488. Epub 2020 Dec 22. Cancer Res. 2021. PMID: 33355182
Type 2 diabetes and hearing loss.
Hong O, Buss J, Thomas E. Hong O, et al. Among authors: buss j. Dis Mon. 2013 Apr;59(4):139-46. doi: 10.1016/j.disamonth.2013.01.004. Dis Mon. 2013. PMID: 23507353 Review. No abstract available.
Mitochondrial response of glioma cells to temozolomide.
Lenz LS, Torgo D, Buss JH, Pereira LC, Bueno M, Filippi-Chiela EC, Lenz G. Lenz LS, et al. Among authors: buss jh. Exp Cell Res. 2023 Dec 15;433(2):113825. doi: 10.1016/j.yexcr.2023.113825. Epub 2023 Oct 21. Exp Cell Res. 2023. PMID: 37866459
Iron chelators in cancer chemotherapy.
Buss JL, Greene BT, Turner J, Torti FM, Torti SV. Buss JL, et al. Curr Top Med Chem. 2004;4(15):1623-35. doi: 10.2174/1568026043387269. Curr Top Med Chem. 2004. PMID: 15579100 Review.
239 results